chartexchange

ORGO
Organogenesis Holdings Inc. Class A Common Stock
stockNASDAQ

At CloseOct 14, 2026 3:59:56 PM EDT
1.13USD-6.612%(-0.08)652,852
Pre-marketOct 14, 2026 9:29:30 AM EDT
1.21USD0.000%(0.00)
After-hoursOct 14, 2026 4:36:30 PM EDT
1.19USD+5.310%(+0.06)
0.9900Bid1.1400Ask0.1500Spread
Loading…
Loading…
146.37M
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Canton, MA, USA
Previous Close
$1.21
Beta
1.22
52-Week High
$7.08 2025-11-11
52-Week Low
$1.20 2026-10-13
SMA 50
$1.61
SMA 200
$2.61
Avg. Vol 10D
734,653
Avg. Vol 30D
687,182
Avg. Vol 90D
759,419
Relative Vol
0.77
128.67M
57.38M
15,002,130
0.5400%
85,841
Nov 5, 2026 (21d)
ORGO Profile

headquartered in canton, massachusetts, organogenesis inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. organogenesis' versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.

ORGO Performance
PeriodPriceDateChangeBeta
1W1.322026-10-07-13.83%4.212
1M1.502026-09-14-24.17%0.344
3M2.342026-07-14-51.39%-0.170
6M2.512026-04-14-54.68%0.479
1Y4.002025-10-14-71.56%1.222
2Y3.092024-10-14-63.19%—
5Y11.152021-10-14-89.80%1.584
ORGO Stock Summary

Organogenesis Holdings Inc. Class A Common Stock (NASDAQ:ORGO) stock price today is $1.14, and today's volume is 529,297. ORGO is down 5.992% today. The 30 day average volume is 687,182. ORGO market cap is $146.37M with 128.67M shares outstanding.